Vaxcyte, Inc. — Director's Dealing 2021

Aug 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-08-12

Reporting Person: Wright-Mitchell Jane (General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-12	Common Stock	M	10000	$2.03	Acquired	13125	Direct
2021-08-12	Common Stock	S	10000	$26.00	Disposed	3125	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-08-12	Stock Option (right to buy)	$2.03	M	10000	Disposed	2029-03-20	Common Stock (10000)	Direct

Footnotes

F1: Includes 1,563 shares acquired under the Employment Stock Purchase Plan on May 17, 2021.

F2: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3: 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter.